| How long does the manufacturing and testing of Rabies Vaccine, Human take? | Manufacturing of Rabies Vaccine, Human is a complex biological process and require a
minimum of 3-4 months for manufacture and testing. | 1. Manufacturing of Rabies Vaccine, Human is a complex biological process and require a
minimum of 3-4 months for manufacture and testing. Accordingly, the States/
procurement agencies may be sensitized about the minimum lead time required for
supply, and plan.
2. Annual requirement of Rabies Vaccine, Human & Anti Rabies serum must be calculated
4-6 months in advance. Requirement must include 10% Wastage factor and buffer stock
for three months (As lead time from order placement to actual delivery of vaccines).
Accordingly, the tender/ purchase order needs to be placed in advance.
3. As per the Drugs and Cosmetics Rules, 1945, the batch of Rabies Vaccine, Human has to
be released by the manufacturer after testing in manufacturer’s laboratory and after
ensuring that the vaccine complies with the specifications. It is also mandatory, as per
procedures defined, to submit the samples of Rabies Vaccine, Human along with
protocols to Central Drugs Laboratory (CDL), Kasauli for evaluation and lot release
before it is supplied in the country. Normally, testing of Rabies vaccine, Human takes
approximately 3 to 4 weeks.
4. Tenders should be issued for fixed quantities rather than the rate contracts.
5. Rabies Vaccine, Human & Anti Rabies serum stock must be monitored on regular basis.
Monitor the district/ institute wise stock situation and accordingly, plan the supply based
on consumpti | 3 | factual | 1.0 | https://ncdc.mohfw.gov.in/uploads/pdf/COH6.pdf | Manufacturing of Rabies Vaccine, Human is a complex biological process and require a
minimum of 3-4 months for manufacture and testing. | 1 | [{"evidence_id":"B000004","location":{"page":1,"block":4,"bbox":[99.02,135.97,552.1,661.73],"column":null,"reading_order":4}}] | 1.0 | valid |
| What should states and procurement agencies be sensitized about regarding vaccine supply? | Accordingly, the States/
procurement agencies may be sensitized about the minimum lead time required for
supply, and plan. | 1. Manufacturing of Rabies Vaccine, Human is a complex biological process and require a
minimum of 3-4 months for manufacture and testing. Accordingly, the States/
procurement agencies may be sensitized about the minimum lead time required for
supply, and plan.
2. Annual requirement of Rabies Vaccine, Human & Anti Rabies serum must be calculated
4-6 months in advance. Requirement must include 10% Wastage factor and buffer stock
for three months (As lead time from order placement to actual delivery of vaccines).
Accordingly, the tender/ purchase order needs to be placed in advance.
3. As per the Drugs and Cosmetics Rules, 1945, the batch of Rabies Vaccine, Human has to
be released by the manufacturer after testing in manufacturer’s laboratory and after
ensuring that the vaccine complies with the specifications. It is also mandatory, as per
procedures defined, to submit the samples of Rabies Vaccine, Human along with
protocols to Central Drugs Laboratory (CDL), Kasauli for evaluation and lot release
before it is supplied in the country. Normally, testing of Rabies vaccine, Human takes
approximately 3 to 4 weeks.
4. Tenders should be issued for fixed quantities rather than the rate contracts.
5. Rabies Vaccine, Human & Anti Rabies serum stock must be monitored on regular basis.
Monitor the district/ institute wise stock situation and accordingly, plan the supply based
on consumpti |
| When should annual requirements of Rabies Vaccine, Human and Anti Rabies Serum be calculated? | Annual requirement of Rabies Vaccine, Human & Anti Rabies serum must be calculated
4-6 months in advance. Requirement must include 10% Wastage factor and buffer stock
for three months (As lead time from order placement to actual delivery of vaccines). | 1. Manufacturing of Rabies Vaccine, Human is a complex biological process and require a
minimum of 3-4 months for manufacture and testing. Accordingly, the States/
procurement agencies may be sensitized about the minimum lead time required for
supply, and plan.
2. Annual requirement of Rabies Vaccine, Human & Anti Rabies serum must be calculated
4-6 months in advance. Requirement must include 10% Wastage factor and buffer stock
for three months (As lead time from order placement to actual delivery of vaccines).
Accordingly, the tender/ purchase order needs to be placed in advance.
3. As per the Drugs and Cosmetics Rules, 1945, the batch of Rabies Vaccine, Human has to
be released by the manufacturer after testing in manufacturer’s laboratory and after
ensuring that the vaccine complies with the specifications. It is also mandatory, as per
procedures defined, to submit the samples of Rabies Vaccine, Human along with
protocols to Central Drugs Laboratory (CDL), Kasauli for evaluation and lot release
before it is supplied in the country. Normally, testing of Rabies vaccine, Human takes
approximately 3 to 4 weeks.
4. Tenders should be issued for fixed quantities rather than the rate contracts.
5. Rabies Vaccine, Human & Anti Rabies serum stock must be monitored on regular basis.
Monitor the district/ institute wise stock situation and accordingly, plan the supply based
on consumpti |
| What type of tenders should be issued for vaccine procurement? | Tenders should be issued for fixed quantities rather than the rate contracts. | der placement to actual delivery of vaccines).
Accordingly, the tender/ purchase order needs to be placed in advance.
3. As per the Drugs and Cosmetics Rules, 1945, the batch of Rabies Vaccine, Human has to
be released by the manufacturer after testing in manufacturer’s laboratory and after
ensuring that the vaccine complies with the specifications. It is also mandatory, as per
procedures defined, to submit the samples of Rabies Vaccine, Human along with
protocols to Central Drugs Laboratory (CDL), Kasauli for evaluation and lot release
before it is supplied in the country. Normally, testing of Rabies vaccine, Human takes
approximately 3 to 4 weeks.
4. Tenders should be issued for fixed quantities rather than the rate contracts.
5. Rabies Vaccine, Human & Anti Rabies serum stock must be monitored on regular basis.
Monitor the district/ institute wise stock situation and accordingly, plan the supply based
on consumption. If necessary, additional procurement order may be placed.
6. The States shall analyse average time required for completing tender process to actual
placement of order and accordingly, the procurement procedures to be started well in
advance to avoid shortage of Rabies Vaccine, Human & Anti Rabies serum supply.
7. The State Authorities need to be sensitized to analyse their annual requirement and the
lead time required for completing all procedures well in advanc |
| What must be done to monitor Rabies Vaccine, Human and Anti Rabies Serum stock? | Rabies Vaccine, Human & Anti Rabies serum stock must be monitored on regular basis.
Monitor the district/ institute wise stock situation and accordingly, plan the supply based
on consumption. If necessary, additional procurement order may be placed. | e batch of Rabies Vaccine, Human has to
be released by the manufacturer after testing in manufacturer’s laboratory and after
ensuring that the vaccine complies with the specifications. It is also mandatory, as per
procedures defined, to submit the samples of Rabies Vaccine, Human along with
protocols to Central Drugs Laboratory (CDL), Kasauli for evaluation and lot release
before it is supplied in the country. Normally, testing of Rabies vaccine, Human takes
approximately 3 to 4 weeks.
4. Tenders should be issued for fixed quantities rather than the rate contracts.
5. Rabies Vaccine, Human & Anti Rabies serum stock must be monitored on regular basis.
Monitor the district/ institute wise stock situation and accordingly, plan the supply based
on consumption. If necessary, additional procurement order may be placed.
6. The States shall analyse average time required for completing tender process to actual
placement of order and accordingly, the procurement procedures to be started well in
advance to avoid shortage of Rabies Vaccine, Human & Anti Rabies serum supply.
7. The State Authorities need to be sensitized to analyse their annual requirement and the
lead time required for completing all procedures well in advance, to guard against
shortages in supply of Rabies Vaccine, Human & Anti Rabies serum.
8. Anti-rabies vaccine and Anti rabies serum is part of essential drug list of Na |
| What should states analyze to avoid shortages of Rabies Vaccine, Human and Anti Rabies Serum? | The States shall analyse average time required for completing tender process to actual
placement of order and accordingly, the procurement procedures to be started well in
advance to avoid shortage of Rabies Vaccine, Human & Anti Rabies serum supply. | es of Rabies Vaccine, Human along with
protocols to Central Drugs Laboratory (CDL), Kasauli for evaluation and lot release
before it is supplied in the country. Normally, testing of Rabies vaccine, Human takes
approximately 3 to 4 weeks.
4. Tenders should be issued for fixed quantities rather than the rate contracts.
5. Rabies Vaccine, Human & Anti Rabies serum stock must be monitored on regular basis.
Monitor the district/ institute wise stock situation and accordingly, plan the supply based
on consumption. If necessary, additional procurement order may be placed.
6. The States shall analyse average time required for completing tender process to actual
placement of order and accordingly, the procurement procedures to be started well in
advance to avoid shortage of Rabies Vaccine, Human & Anti Rabies serum supply.
7. The State Authorities need to be sensitized to analyse their annual requirement and the
lead time required for completing all procedures well in advance, to guard against
shortages in supply of Rabies Vaccine, Human & Anti Rabies serum.
8. Anti-rabies vaccine and Anti rabies serum is part of essential drug list of National Health
Mission (NHM). Budget for Rabies Vaccine, Human & Anti Rabies serum may be
proposed under NHM PIP under national free drug initiative.
9. As per national guidelines, the preferred route of administration for Rabies Vaccine,
Human is Intrad |
| What is the status of Anti-rabies vaccine and Anti Rabies Serum in the National Health Mission? | Anti-rabies vaccine and Anti rabies serum is part of essential drug list of National Health
Mission (NHM). | rict/ institute wise stock situation and accordingly, plan the supply based
on consumption. If necessary, additional procurement order may be placed.
6. The States shall analyse average time required for completing tender process to actual
placement of order and accordingly, the procurement procedures to be started well in
advance to avoid shortage of Rabies Vaccine, Human & Anti Rabies serum supply.
7. The State Authorities need to be sensitized to analyse their annual requirement and the
lead time required for completing all procedures well in advance, to guard against
shortages in supply of Rabies Vaccine, Human & Anti Rabies serum.
8. Anti-rabies vaccine and Anti rabies serum is part of essential drug list of National Health
Mission (NHM). Budget for Rabies Vaccine, Human & Anti Rabies serum may be
proposed under NHM PIP under national free drug initiative.
9. As per national guidelines, the preferred route of administration for Rabies Vaccine,
Human is Intradermal. It is cost effective and requires 0.2 ml/ Visit/patient for
intradermal route vs. 1 ml/visit/patient for intra muscular route).
10. In case of shortage of Rabies vaccine, Human, please inform to National Pharmaceutical
Pricing Authority (NPPA), Department of Pharmaceuticals (DoP) or Ministry of Health
and Family Welfare (MoHFW) for addressing the issue. Non-supply of Rabies vaccine,
Human due to pendency of bill |
| Under which initiative can the budget for Rabies Vaccine, Human and Anti Rabies Serum be proposed? | Budget for Rabies Vaccine, Human & Anti Rabies serum may be
proposed under NHM PIP under national free drug initiative. | al procurement order may be placed.
6. The States shall analyse average time required for completing tender process to actual
placement of order and accordingly, the procurement procedures to be started well in
advance to avoid shortage of Rabies Vaccine, Human & Anti Rabies serum supply.
7. The State Authorities need to be sensitized to analyse their annual requirement and the
lead time required for completing all procedures well in advance, to guard against
shortages in supply of Rabies Vaccine, Human & Anti Rabies serum.
8. Anti-rabies vaccine and Anti rabies serum is part of essential drug list of National Health
Mission (NHM). Budget for Rabies Vaccine, Human & Anti Rabies serum may be
proposed under NHM PIP under national free drug initiative.
9. As per national guidelines, the preferred route of administration for Rabies Vaccine,
Human is Intradermal. It is cost effective and requires 0.2 ml/ Visit/patient for
intradermal route vs. 1 ml/visit/patient for intra muscular route).
10. In case of shortage of Rabies vaccine, Human, please inform to National Pharmaceutical
Pricing Authority (NPPA), Department of Pharmaceuticals (DoP) or Ministry of Health
and Family Welfare (MoHFW) for addressing the issue. Non-supply of Rabies vaccine,
Human due to pendency of bills should not be referred to DoP/MoHFW/CDSCO. |
| What is included in the essential drug list of the National Health Mission? | Anti-rabies vaccine and Anti rabies serum is part of essential drug list of National Health
Mission (NHM). | rict/ institute wise stock situation and accordingly, plan the supply based
on consumption. If necessary, additional procurement order may be placed.
6. The States shall analyse average time required for completing tender process to actual
placement of order and accordingly, the procurement procedures to be started well in
advance to avoid shortage of Rabies Vaccine, Human & Anti Rabies serum supply.
7. The State Authorities need to be sensitized to analyse their annual requirement and the
lead time required for completing all procedures well in advance, to guard against
shortages in supply of Rabies Vaccine, Human & Anti Rabies serum.
8. Anti-rabies vaccine and Anti rabies serum is part of essential drug list of National Health
Mission (NHM). Budget for Rabies Vaccine, Human & Anti Rabies serum may be
proposed under NHM PIP under national free drug initiative.
9. As per national guidelines, the preferred route of administration for Rabies Vaccine,
Human is Intradermal. It is cost effective and requires 0.2 ml/ Visit/patient for
intradermal route vs. 1 ml/visit/patient for intra muscular route).
10. In case of shortage of Rabies vaccine, Human, please inform to National Pharmaceutical
Pricing Authority (NPPA), Department of Pharmaceuticals (DoP) or Ministry of Health
and Family Welfare (MoHFW) for addressing the issue. Non-supply of Rabies vaccine,
Human due to pendency of bill |
| What is the preferred route of administration for Rabies Vaccine, Human? | As per national guidelines, the preferred route of administration for Rabies Vaccine,
Human is Intradermal. It is cost effective and requires 0.2 ml/ Visit/patient for
intradermal route vs. 1 ml/visit/patient for intra muscular route). | cedures to be started well in
advance to avoid shortage of Rabies Vaccine, Human & Anti Rabies serum supply.
7. The State Authorities need to be sensitized to analyse their annual requirement and the
lead time required for completing all procedures well in advance, to guard against
shortages in supply of Rabies Vaccine, Human & Anti Rabies serum.
8. Anti-rabies vaccine and Anti rabies serum is part of essential drug list of National Health
Mission (NHM). Budget for Rabies Vaccine, Human & Anti Rabies serum may be
proposed under NHM PIP under national free drug initiative.
9. As per national guidelines, the preferred route of administration for Rabies Vaccine,
Human is Intradermal. It is cost effective and requires 0.2 ml/ Visit/patient for
intradermal route vs. 1 ml/visit/patient for intra muscular route).
10. In case of shortage of Rabies vaccine, Human, please inform to National Pharmaceutical
Pricing Authority (NPPA), Department of Pharmaceuticals (DoP) or Ministry of Health
and Family Welfare (MoHFW) for addressing the issue. Non-supply of Rabies vaccine,
Human due to pendency of bills should not be referred to DoP/MoHFW/CDSCO. |